EUVIMEDEUVIMED entdecken
Open Access

Dissolvable microneedles loaded with denosumab alleviate knee osteoarthritis in rodent and canine models by inhibiting macrophage senescence

Chaochang Ming, Duohang Bi, Hongtao Tian, Weijian Liu, Haitao Li, Yuxiang Hu, Zhenyu Song, Dongdong Xu, Hao Xu, Hongyan Li, Shenghui Lan, Weihua Xu und 12 weitere

Theranostics · 2026

DOI: 10.7150/thno.116970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Chaochang Ming und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. Hauptthemen laut MEDLINE: Macrophages, Cellular Senescence, Denosumab, Osteoarthritis, Knee. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Osteoarthritis (OA) lacks disease-modifying therapies. Although systemic denosumab delays OA progression, it causes uneven drug distribution and off-target effects, whereas intra-articular injections are invasive and risk joint infection. We aimed to develop a minimally invasive microneedle platform that delivers denosumab locally to achieve therapeutic efficacy comparable to intra-articular injection while avoiding systemic exposure.

Methods

A dissolvable denosumab-loaded microneedle array (MNs@De) was fabricated for transcutaneous intra-articular delivery. OA was induced in rodents and Beagle dogs; animals were treated with MNs@De, systemic denosumab, intra-articular denosumab, or vehicle. Synovial inflammation, cartilage erosion, and pain were evaluated histologically and behaviorally. Single-cell RNA sequencing and immunofluorescence were performed to assess macrophage senescence and chondrocyte metabolism. Secretion of pro-inflammatory and catabolic factors was quantified in vitro using senescent macrophage-chondrocyte co-cultures.

Results

MNs@De delivered denosumab effectively into joints, significantly reducing synovial inflammation, cartilage erosion, and pain compared with systemic administration and achieving outcomes comparable to intra-articular injection. Single-cell profiling revealed that denosumab markedly decreased senescent macrophage abundance within synovial tissue. Mechanistically, denosumab inhibited senescent macrophage-derived pro-inflammatory and catabolic factor release, thereby shifting chondrocytes from catabolic to anabolic states.

Conclusions

Targeting senescent macrophages via MNs@De attenuates OA progression without requiring intra-articular injections or increasing systemic drug exposure. Microneedle-mediated denosumab delivery offers a minimally invasive, localized therapeutic strategy for OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesCellular SenescenceDenosumabOsteoarthritis, KneeBone Density Conservation AgentsAnimalsDogsNeedlesDisease Models, AnimalInjections, Intra-ArticularMiceRatsChondrocytesMaleDrug Delivery Systems

Substanzen

DenosumabBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
  • Department of Orthopedics, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, Henan, China.
  • Department of Orthopedics, Xinxiang Medical University, Xinxiang 453003, Henan, China.
  • Department of Orthopedics, Huaxian Orthopedic Hospital, Anyang 456400, Henan, China.
  • Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science an…
  • Department of Orthopedics, Affiliated Hospital of Guizhou Medical University, Guiyang 55000, China.

Zitieren

APA

Ming, C., Bi, D., Tian, H., Liu, W., Li, H., Hu, Y., Song, Z., Xu, D., Xu, H., Li, H., Lan, S., Xu, W., Chen, W., Li, Q., Feng, J., Cao, Q., Wang, X., Fan, P., Zhu, J., …, & Tong, W. (2026). Dissolvable microneedles loaded with denosumab alleviate knee osteoarthritis in rodent and canine models by inhibiting macrophage senescence. Theranostics. https://doi.org/10.7150/thno.116970

Vancouver

Ming C, Bi D, Tian H, Liu W, Li H, Hu Y, et al. Dissolvable microneedles loaded with denosumab alleviate knee osteoarthritis in rodent and canine models by inhibiting macrophage senescence. Theranostics. 2026. doi:10.7150/thno.116970

BibTeX
@article{Ming2026,
  author = {Ming, Chaochang and Bi, Duohang and Tian, Hongtao and Liu, Weijian and Li, Haitao and Hu, Yuxiang and Song, Zhenyu and Xu, Dongdong and Xu, Hao and Li, Hongyan and Lan, Shenghui and Xu, Weihua and Chen, Wei and Li, Qiong and Feng, Jiawei and Cao, Qianqian and Wang, Xiaoyang and Fan, Panlong and Zhu, Jintao and Yu, Wei and Ming, Chaoge and Dai, Zhipeng and Liu, Yijing and Tong, Wei},
  title = {Dissolvable microneedles loaded with denosumab alleviate knee osteoarthritis in rodent and canine models by inhibiting macrophage senescence},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.116970}
}
Kostenlos starten →